Advisory Services Network’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Advisory Services Network’s Portfolio TCON Stock Details TCON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-100	Closed	-$3.78K	–	3850
2023 Q1	$3.78K	Hold	100	–	–	﹤0.01%	3245
2022 Q4	$2.98K	Buy	+100	New	+$3.02K	﹤0.01%	3291
2021 Q3	–	Sell	-50	Closed	-$6K	–	3389
2021 Q2	$6K	Buy	+50	New	+$6.92K	﹤0.01%	3029
2021 Q1	–	Sell	-50	Closed	-$12K	–	3082
2020 Q4	$12K	Buy	+50	New	+$6.96K	﹤0.01%	2361

Other funds holding TCON

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Advisory Services Network's TCON Position: Q2 2023 in Review

Advisory Services Network sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q2 2023, closing a stake of 100 shares — an estimated $3.78K sold.

Advisory Services Network first reported a position in TCON in Q4 2020 and held it in 4 quarters. The position peaked at $12K in Q4 2020. 27 funds tracked by Wall St. Rank hold TCON as of Q2 2023.

Advisory Services Network reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Advisory Services Network sold 100 TRACON Pharmaceuticals, Inc. Common Stock shares in Q2 2023, an estimated $3.78K.
Advisory Services Network first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q4 2020 and held it in 4 quarters.
Advisory Services Network's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $12K in Q4 2020.
27 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q2 2023.

Based on Advisory Services Network's 13F filing for Q2 2023, filed 9 Aug 2023.